Infusystem Holdings, INC 10-Q quarterly reports

InfuSystem Holdings, Inc. announced Q2 2026 results showing a 2.6% increase in net revenues driven by strong Patient Services growth, alongside improved gross margins despite higher operating expenses.

InfuSystem reports Q1 2026 net income of $1.0 million, driven by growth in Patient Services despite a decline in Device Solutions revenue.

InfuSystem Holdings, Inc. announced significant increases in net income and gross profit for both the third quarter and first nine months of 2025, driven by Patient Services growth and improved Device Solutions margins.

InfuSystem Holdings, Inc. announced significant revenue and profit increases for the second quarter and first half of 2025, driven by growth in both Patient Services and Device Solutions segments.

InfuSystem Holdings, Inc. reports an increase in net revenues and gross profit for the first quarter of 2025 compared to the same period in 2024, driven by growth in both Patient Services and Device Solutions segments.

InfuSystem Holdings, Inc., a leading provider of infusion pumps and related services, announced a 10.7% increase in net revenues for Q3 2024, driven by growth in both its Patient Services and Device Solutions segments.

InfuSystem Holdings saw a revenue increase in the second quarter of 2024, but also reported a material weakness in internal controls.

InfuSystem Holdings saw a revenue increase in Q1 2024, but also experienced a net loss due to higher operating expenses.